Loading clinical trials...

Mobile Instant Messaging-based Lifestyle Intervention for Gestational Diabetes Prevention | Clinical Trials | Clareo Health

RECRUITINGNA

Mobile Instant Messaging-based Lifestyle Intervention for Gestational Diabetes Prevention

Mobile Instant Messaging-based Lifestyle Interventions for Preventing Gestational Diabetes in High-risk Pregnant Women: a Randomised Controlled Trial

NCT06061991•The University of Hong Kong

View on ClinicalTrials.gov

Summary

The goal of this randomised controlled trial is to test the effectiveness of a mobile instant messaging-based lifestyle intervention in pregnant women at risk of gestational diabetes

Detailed Description

Gestational diabetes mellitus (GDM) is one of the most common medical conditions during pregnancy, affecting about 1 in 7 live births worldwide. There remains a lack of proven preventive strategies for GDM that could be readily adopted in clinical practice. Recent studies have suggested that lifestyle intervention delivered via mobile phone could help pregnant women prevent GDM, but more evidence is needed. This study aims to test a mobile instant messaging-based lifestyle intervention for GDM prevention in pregnant women at risk of GDM.

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•1. Ethnic Chinese singleton pregnant woman in \<14 weeks of gestation
•2. Aged 18 years or above
•3. Own a mobile phone with an instant messaging app
•4. Not participating in similar trials on diabetes or lifestyle modifications
•5. Have at least one of the following risk factors for GDM:
•* Age ≥35 years at the expected date of delivery
•* Body mass index (BMI) ≥ 25 kg/m2 pre-pregnancy or in the first trimester
•* Family history of diabetes in first-degree relative
•* Previous GDM or delivered a baby with birthweight ≥4 kg

Exclusion Criteria

•Pre-existing diabetes or other medical conditions that may affect metabolism (e.g., thyroid disorders) or psychiatric disorders

Locations (4)

Kwong Wah Hospital

Hong Kong, Hong Kong

Princess Margaret Hospital

Hong Kong, Hong Kong

Queen Mary Hospital/ Tsan Yuk Hospital

Hong Kong, Hong Kong

United Christian Hospital/ Tseung Kwan O Hospital

Hong Kong, Hong Kong

Key Dates

Start Date

January 30, 2024

Primary Completion Date

July 30, 2026

Completion Date

October 30, 2026

Last Updated

September 19, 2024

Enrollment

944

ESTIMATED participants

Conditions

Gestational Diabetes

Interventions

Mobile instant messaging-based lifestyle intervention

BEHAVIORAL

Text messaging reminders

BEHAVIORAL

Brief advice on GDM prevention

BEHAVIORAL

Usual care

BEHAVIORAL

Contacts

Tzu Tsun Luk, PhD, RN

CONTACT

+852-3917-7574 luktt@connect.hku.hk

The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus

NCT06648174

Gestational Diabetes MellitusContinuous Glucose Monitoring

View study

RECRUITINGPHASE2

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

NCT06948825

Weight LossGestational Diabetes Mellitus in Pregnancy+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Mobile Instant Messaging-based Lifestyle Intervention for Gestational Diabetes Prevention

Inclusion Criteria

Exclusion Criteria

The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

Determining the Effect of Food Ordering on Blood Glucose In Gestational Diabetes Mellitus (DEFI-GDM)

Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia

Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE